Spotlight On... Pathway Genomics pays $4M to settle kickback claims; Pande discusses Andreessen Horowitz's $200M bio fund; NIH sets mHealth evidence goal; and more...

Pathway Genomics has agreed to pay $4 million to settle a dispute with the U.S. Department of Justice (DOJ). The genomic testing lab was accused of providing kickbacks to healthcare providers in return for patient referrals. In a statement to reveal the settlement, Pathway said it isn't admitting to any wrongdoing and "may debate some of the merits of the DOJ's allegations." Release | More

> Vijay Pande outlined his vision for Andreessen Horowitz's $200 million bio fund. Q&A

> The NIH committed to generating evidence on mHealth apps by 2020. Article

> Datatrak continued to fightback against activist investors ahead of its upcoming annual meeting. Release

> OmniComm Systems revealed a biopharma company is using its EDC system across its entire pipeline. More

> EnsoData discussed its use of software to speed up the analysis of sleep data. Piece

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.